Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Junson Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 13
Average round size
info
The average size of a deal this fund participated in
$36M
Portfolio companies 12
Rounds per year 1.18
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.08
Key employees 3

Areas of investment

  • Biotechnology
  • Health Care
  • Security
  • Manufacturing
  • Pharmaceutical
Summary

The fund was located in Asia if to be more exact in Hong Kong. The main office of represented VC is situated in the Hong Kong.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Junson Capital, startups are often financed by YuanMing Capital, Viventures, Sinopharm Capital. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, StartX (Stanford-StartX Fund), South China Venture Capital.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2019. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.

The overall number of key employees were 3.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Ansun BioPharma, Apollomics, MultiVu Technologies. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Security, Medical. The fund has no exact preference in a number of founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Junson Capital:
Typical Co-investors
Junson Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Junson Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ADP New Jersey, Roseland, United States
AION Capital Partners India, Maharashtra, Mumbai
Black Coral Capital Boston, Massachusetts, United States
Cisco Entrepreneurs in Residence California, San Jose, United States
Enrico Investments -
G-Bar Ventures -
Guangyi Chenxin Touzi China, Fujian, Xiamen
Idea Foundry Pennsylvania, Pittsburgh, United States
Infinite Potential Group -
KB Partners Highland Park, Illinois, United States
Manresa Ventures California, San Francisco, United States
Mey Capital Matrix Bayern, Germany, München
Moonshots Capital California, Los Angeles, United States
Muse Capital -
QPDigital Kyiv, Ukraine, Київська міська громада
Schechter Private Capital -
Sempra Energy California, San Diego, United States
Shin Kong Life Insurance -
Tongxing Caifu China, Jiangsu, Suzhou

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Full-Life Technologies

Health Care
Manufacturing
Pharmaceutical
$47M03 Jan 2024 Shanghai, Shanghai, China

Corsair Pharma

$23M20 Sep 2023 Sunnyvale, California, United States

Worg Pharmaceuticals

Biotechnology
$61M14 Sep 2022 Shangcheng District, Zhejiang, China

BridGene Biosciences

Biotechnology
Therapeutics
$38M27 Jul 2022 Sunnyvale, California, United States

Leo Cancer Care

Health Care
$25M20 Jul 2021 Surrey, England, United Kingdom

Biotechnology
$30M18 Jan 2021 Shangcheng District, Zhejiang, China

WiBotic

Battery
Electrical Equipment
Energy Storage
Robotics
Wireless
$5M11 Jun 2020 Seattle, Washington, United States

RaySecur

Security
$3M05 Dec 2019 Cambridge, Massachusetts, United States

Biopharma
Biotechnology
Clinical Trials
Health Care
Medical
$100M15 Oct 2019 San Diego, California, United States
News
Leo Cancer Care Raises $25.3M in Series B Funding

– Leo Cancer Care is a Horley, UK- and Middleton, Wisconsin-based radiation therapy startup.
– The company raised $25.3m in Series B funding.
– The round was led by Pureland Global Venture, Yu Galaxy, WARF, Alumni Ventures, Junson Capital and Serra Ventures as well as industry leaders CHC, Cosylab, Toret Devices and Radiation Business Solutions.
– The new investment will be used to expand their teams in the US, Europe and Singapore and continue the development of its upright radiotherapy solutions.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Junson Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 13
Average round size 36M
Rounds per year 1.18
Peak activity year 2019
Lead investments 0
Follow on index 0.08
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Full-Life Technologies

Health Care
Manufacturing
Pharmaceutical
$47M03 Jan 2024 Shanghai, Shanghai, China

Corsair Pharma

$23M20 Sep 2023 Sunnyvale, California, United States

Worg Pharmaceuticals

Biotechnology
$61M14 Sep 2022 Shangcheng District, Zhejiang, China

BridGene Biosciences

Biotechnology
Therapeutics
$38M27 Jul 2022 Sunnyvale, California, United States

Leo Cancer Care

Health Care
$25M20 Jul 2021 Surrey, England, United Kingdom

Biotechnology
$30M18 Jan 2021 Shangcheng District, Zhejiang, China

WiBotic

Battery
Electrical Equipment
Energy Storage
Robotics
Wireless
$5M11 Jun 2020 Seattle, Washington, United States

RaySecur

Security
$3M05 Dec 2019 Cambridge, Massachusetts, United States

Biopharma
Biotechnology
Clinical Trials
Health Care
Medical
$100M15 Oct 2019 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: